ADIL ▲ +41.5% - Adial Pharmaceuticals, Inc. $ADIL - Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis 28-OCT-2026 04:02 PM ET